These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33330902)

  • 1. Microbiome Data Enhances Predictive Models of Lung Function in People With Cystic Fibrosis.
    Zhao CY; Hao Y; Wang Y; Varga JJ; Stecenko AA; Goldberg JB; Brown SP
    J Infect Dis; 2021 Jun; 223(12 Suppl 2):S246-S256. PubMed ID: 33330902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
    Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
    J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung function and microbiota diversity in cystic fibrosis.
    Cuthbertson L; Walker AW; Oliver AE; Rogers GB; Rivett DW; Hampton TH; Ashare A; Elborn JS; De Soyza A; Carroll MP; Hoffman LR; Lanyon C; Moskowitz SM; O'Toole GA; Parkhill J; Planet PJ; Teneback CC; Tunney MM; Zuckerman JB; Bruce KD; van der Gast CJ
    Microbiome; 2020 Apr; 8(1):45. PubMed ID: 32238195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.
    de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28951476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years.
    Acosta N; Whelan FJ; Somayaji R; Poonja A; Surette MG; Rabin HR; Parkins MD
    Ann Am Thorac Soc; 2017 Aug; 14(8):1288-1297. PubMed ID: 28541746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
    Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
    Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertonic Saline as a Useful Tool for Sputum Induction and Pathogen Detection in Cystic Fibrosis.
    Ferreira ACM; Marson FAL; Cohen MA; Bertuzzo CS; Levy CE; Ribeiro AF; Ribeiro JD
    Lung; 2017 Aug; 195(4):431-439. PubMed ID: 28455785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung microbiota across age and disease stage in cystic fibrosis.
    Coburn B; Wang PW; Diaz Caballero J; Clark ST; Brahma V; Donaldson S; Zhang Y; Surendra A; Gong Y; Elizabeth Tullis D; Yau YC; Waters VJ; Hwang DM; Guttman DS
    Sci Rep; 2015 May; 5():10241. PubMed ID: 25974282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.
    Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD
    PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic footprint of the airway bacterial community in cystic fibrosis.
    Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
    Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
    Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
    Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis.
    Acosta N; Heirali A; Somayaji R; Surette MG; Workentine ML; Sibley CD; Rabin HR; Parkins MD
    Thorax; 2018 Nov; 73(11):1016-1025. PubMed ID: 30135091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability.
    Caverly LJ; Lu J; Carmody LA; Kalikin LM; Shedden K; Opron K; Azar M; Cahalan S; Foster B; VanDevanter DR; Simon RH; LiPuma JJ
    Ann Am Thorac Soc; 2019 Dec; 16(12):1534-1542. PubMed ID: 31415187
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of inhaled aztreonam on the cystic fibrosis lung microbiome.
    Heirali AA; Workentine ML; Acosta N; Poonja A; Storey DG; Somayaji R; Rabin HR; Whelan FJ; Surette MG; Parkins MD
    Microbiome; 2017 May; 5(1):51. PubMed ID: 28476135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
    Zemanick ET; Harris JK; Wagner BD; Robertson CE; Sagel SD; Stevens MJ; Accurso FJ; Laguna TA
    PLoS One; 2013; 8(4):e62917. PubMed ID: 23646159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.
    Botterel F; Angebault C; Cabaret O; Stressmann FA; Costa JM; Wallet F; Wallaert B; Bruce K; Delhaes L
    Mycopathologia; 2018 Feb; 183(1):171-183. PubMed ID: 28766039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis.
    Frey DL; Boutin S; Dittrich SA; Graeber SY; Stahl M; Wege S; Herth FJF; Sommerburg O; Schultz C; Mall MA; Dalpke AH
    J Cyst Fibros; 2021 Sep; 20(5):754-760. PubMed ID: 33431308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Airway Microbiome Diversity and Pulmonary Function.
    Bozzella MJ; Chaney H; Sami I; Koumbourlis A; Bost JE; Zemanick ET; Freishtat RJ; Crandall KA; Hahn A
    Pediatr Infect Dis J; 2021 Nov; 40(11):962-968. PubMed ID: 34269323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis.
    Syed SA; Whelan FJ; Waddell B; Rabin HR; Parkins MD; Surette MG
    Ann Am Thorac Soc; 2016 Dec; 13(12):2132-2142. PubMed ID: 27925791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.